Therefore, we explored the association between the Hb/RDW ratio and overall survival (OS) and assessed the incremental prognostic value of this new inflammatory marker when combined with the International Prognostic Index (IPI) in a contemporary cohort of patients with AR-DLBCL. The gene discussed is GSTM1; the disease is diffuse large B-cell lymphoma.